<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib12">
 <label>12</label>
 <element-citation publication-type="journal" id="sref12">
  <person-group person-group-type="author">
   <name>
    <surname>Hotchkiss</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Colston</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Yende</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Angus</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Moldawer</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Crouser</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>Immune checkpoint inhibition in sepsis: a phase 1b randomized, placebo-controlled, single ascending dose study of antiprogrammed cell death-ligand 1 antibody (BMS-936559)âˆ—</article-title>
  <source>Crit Care Med</source>
  <volume>47</volume>
  <issue>5</issue>
  <year>2019</year>
  <fpage>632</fpage>
  <lpage>642</lpage>
  <pub-id pub-id-type="doi">10.1097/CCM.0000000000003685</pub-id>
  <pub-id pub-id-type="pmid">30747773</pub-id>
 </element-citation>
</ref>
